Yun-feng Z. Li
27 Taiping Road
Haidian, 100850, China
Haidian, 100850, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Targeting Neuroinflammation in Depression: The Integrative Role of Sigma-1 Receptor Modulation.
Journal: Journal of neurochemistry
Published: January 18, 2026
Activation of sigma non-opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive-like behaviours in mice.
Journal: British journal of pharmacology
Published: January 07, 2026
Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling.
Journal: Journal of psychopharmacology (Oxford, England)
Published: November 17, 2025
Role of neural oscillations in depression: highlights on gamma oscillations.
Journal: Translational psychiatry
Published: October 21, 2025
Antidepressant-like effects of ketamine involve CX3CL1/CX3CR1 signaling-mediated synaptic plasticity in the mPFC.
Journal: Translational psychiatry
Published: October 10, 2025
Presence of Astrocytic S1R/5-HT1A Heterocomplex in the mPFC: A Putative Link to S1R Activation Mediated Faster Antidepressant-Like Effects.
Journal: Molecular neurobiology
Published: August 24, 2025
Requirement of sigma-1 receptor (Sig-1R) for boosting the gamma oscillations in the medial prefrontal cortex (mPFC).
Journal: British journal of pharmacology
Published: May 28, 2025
Computational modeling reveals cognitive processes in simple rodent depression tests.
Journal: Cell reports methods
Published: April 08, 2025
Sigma non-opioid intracellular receptor 1 activation relieves post-stroke cognitive impairment via suppressing AIM2-driven inflammatory response.
Journal: British journal of pharmacology
Published: February 20, 2025
The astrocytic sigma-1 receptor constitutes in the fast antidepressant action of hypidone hydrochloride (YL-0919) in rodents.
Journal: Frontiers in pharmacology
Published: January 22, 2025
The impact and mechanisms of YL-IPA08, a potent ligand for the translocator protein (18 kDa) on protection against LPS-induced depression and cognitive dysfunction in rodents.
Journal: Metabolic brain disease
Published: January 02, 2025
Last Updated: 09/26/2026